510(k) Report

510(k) · Cleared

Cleared

Human Iga Liquid Reagent Kit for Use on Spa Plus

K103824510(k) TraditionalCleared Feb 27, 2012424-day reviewClass II21 CFR 866.5510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

The Binding Site · CFN Method, Nephelometric, Immunoglobulins (G, A, M)

Cleared on Feb 27, 2012 as substantially equivalent to K040435 (Roche Diagnostics Corp., 2004) after a 424-day review. Its family tree reaches back 2 generations to 1996. 3 later devices descend from it.

Decided
Feb 27, 2012
Review
424 days
Class
Class II
Product code
CFN
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K955907 (1996). 3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2019: 2 descendants cleared2025: 1 descendant clearedK955907 · Boehringer Mannheim Iga Assay · Boehringer Mannheim Corp. · 1996K040435 · Roche Diagnostics Tina-Quant Iga Gen.2 · Roche Diagnostics Corp. · 2004 · recalled1995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 1 descendant K040435 · Roche Diagnostics Tina-Quant Iga Gen.2 · Roche Diagnostics Corp. · 2004 · recalledK955907 · Boehringer Mannheim Iga Assay · Boehringer Mannheim Corp. · 19960
  1. Root · 2 generations backK955907 Boehringer Mannheim Iga AssayBoehringer Mannheim Corp. · 1996
  2. 1 generation backK040435 Roche Diagnostics Tina-Quant Iga Gen.2Roche Diagnostics Corp. · 2004 · Recalled
  3. This deviceK103824 Human Iga Liquid Reagent Kit for Use on Spa PlusThe Binding Site · 2012
  4. Descendant · cites it directly · 1 of its ownK191985 Optilite IgA KitThe Binding Site Group, Ltd. · 2019
  5. Descendant · 2 generations on · 0 of its ownK250159 Immunoglobulin Isotypes (GAM) for the EXENT Analyser; EXENT AnalyserThe Binding Site Group, Ltd. · 2025 · Recalled
  6. Descendant · cites it directly · 0 of its ownK192116 Human IgA liquid reagent kit for Use on SPAPlusThe Binding Site Group, Ltd. · 2019

Most influential descendants

Showing 3 of 3 · See all
  • K191985Optilite IgA KitThe Binding Site Group, Ltd. · 2019 · cites it directly1descendant
  • K250159Immunoglobulin Isotypes (GAM) for the EXENT Analyser; EXENT AnalyserThe Binding Site Group, Ltd. · 2025 · 2 generations on0descendants
  • K192116Human IgA liquid reagent kit for Use on SPAPlusThe Binding Site Group, Ltd. · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K955907Boehringer Mannheim Iga AssayBoehringer Mannheim Corp.1996—
−1K040435Roche Diagnostics Tina-Quant Iga Gen.2Roche Diagnostics Corp.20041
0 (this device)K103824Human Iga Liquid Reagent Kit for Use on Spa PlusThe Binding Site2012—
+1K191985Optilite IgA KitThe Binding Site Group, Ltd.2019—
+2K250159Immunoglobulin Isotypes (GAM) for the EXENT Analyser; EXENT AnalyserThe Binding Site Group, Ltd.20251
+1K192116Human IgA liquid reagent kit for Use on SPAPlusThe Binding Site Group, Ltd.2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201920
202510
FIG. 1 — Lineage of K103824, 1996–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CFN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CFN device

  1. #1 K233663 N Antisera to Human Immunoglobulins (IgG, IgA…score 8.3 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040435Roche Diagnostics Tina-Quant Iga Gen.2
Summary page 1
…Predicate device We claim substantial equivalence to the Roche IgA Tina Quant Gen 2. on the Modular P( K040435) which measures low level IgA. Similarities and differences to the predicate device To…
Roche Diagnostics Corp.20041

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K191985Optilite IgA KitThe Binding Site Group, Ltd.20191
K192116Human IgA liquid reagent kit for Use on SPAPlusThe Binding Site Group, Ltd.20190

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 3 companies; a new generation was cleared every 8.1 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K191985 (The Binding Site Group, Ltd., 2019) has gone furthest, with 1 descendant of its own.

How does its category compare?

All CFN devices

CFN Method, Nephelometric, Immunoglobulins (G, A, M): FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · CFN

2in 2023

2008: 72009: 42010: 22012: 12013: 42014: 22015: 12017: 12019: 62023: 2
2007high 7 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CFN

28in 2019

2008: 69 days median2009: 160 days median2013: 431 days median2019: 28 days median
2007high 431 (2013) · low 28 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CFN

1in 2023

2014: 52018: 22022: 22023: 1
2007high 5 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CFN

1in 2024

2010: 32012: 32016: 22017: 42018: 22019: 82022: 12024: 1
2007high 8 (2019) · low 0 (2007)2025

MAUDE reports naming product code CFN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
200876900
2009416000
20102—03
20110—00
20121—03
2013443100
20142—50
20151—00
20160—02
20171—04
20180—22
201962808
20200—00
20210—00
20220—21
20232—10
20240—01
20250—00
20260—0—

What is it indicated for?

This kit is intended for the quantitative int vitro determination of human IgA in serum, lithium heparin or EDTA plasma using the Binding Site SPAPLUS turbidimetric analyser. Measurement of IgA aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents. The test results are to be used in conjunction with other clinical and laboratory findings.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K103824: Human Iga Liquid Reagent Kit for Use on Spa Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K103824

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026